Advancing Lymphoma Treatment in Singapore: Personalised Cancer Care at CFCH
Lymphoma, or cancer of the lymph glands is one of the most common types of cancers in Singapore. Diffuse large B-cell lymphoma (DLBCL) is a significant form of lymphoma. A diagnosis of lymphoma, especially Diffuse Large B-Cell Lymphoma (DLBCL), can be overwhelming. But for patients with lymphoma in Singapore, hope for a cure is real […]
DLBCL Journey of Catherine Choo: A story of Hope, Resilience, and Recovery from Lymphoma
Life was humming along beautifully for Catherine Choo. A successful professional and dedicated mother in her late 40s, she thrived at work and home. Her days were packed, but she loved the energy and purpose of juggling career and motherhood. That was until May 2024. From Breathlessness to Diagnosis: The Early Signs of DLBCL In […]
Personalized Pathways in CLL and MCL: Highlights from MSH 2025 by Dr. Joanne Lee
Media At the 2025 Malaysian Society of Haematology (MSH) Annual Scientific Meeting, Dr. Joanne Lee presented two highly anticipated sessions that explored precision medicine approaches in Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL), emphasizing the evolving role of targeted therapy, risk stratification, and individualized care. In her first talk, “Optimizing the Role of […]